The diversification of the US pharmaceutical pipeline is altering the technical requirements placed on bioanalytical testing facilities. According to recent research highlighted in the US Bioanalytical Testing Services Segment Outlook, oncology, immunology, and rare metabolic diseases represent the largest application segments driving volume growth across domestic bioanalytical laboratories.

Oncology and Targeted Immunotherapies

Oncology remains the primary therapeutic area receiving research and development investment in the United States. The development of complex cancer therapies—including bispecific antibodies, immune checkpoint inhibitors, and antibody-drug conjugates (ADCs)—requires multi-faceted bioanalytical testing strategies. ADCs, for example, present unique analytical complexity because testing labs must simultaneously quantify total antibody, conjugated antibody, and free cytotoxic payload in biological matrices.

Cell and Gene Therapy (CGT) Characterization

The commercial growth of cell therapies (such as CAR-T) and gene therapies (utilizing adeno-associated virus vectors) has created new frontiers for US bioanalytical service providers. Characterizing vector shed, transgene expression, biodistribution, and persistence requires specialized molecular assays, such as quantitative Polymerase Chain Reaction (qPCR), droplet digital PCR (ddPCR), and flow cytometry. Contract laboratories that build certified biosafety level (BSL) facilities and expertise in cell biology are capturing significant market share in this high-margin sector.

Peptides and Oligonucleotide Therapeutics

Synthetic peptides and oligonucleotide modalities (including siRNA and antisense oligonucleotides) are expanding rapid treatment options for genetic and metabolic disorders. Bioanalyzing these molecules requires specialized extraction techniques and hybrid LC-MS methods to distinguish parent compounds from active metabolites. As clinical pipelines for RNA-based drugs grow, bioanalytical CROs are expanding targeted assay portfolios to support rapid preclinical-to-clinical translation.

Uncover future growth patterns with expert-driven reports:

Next Generation Sequencing Market Size

Next Generation Sequencing Market Share

Microfluidic Devices Market Trends

Microfluidic Devices Market Growth

Microfluidic Devices Market Demand